TF
Terence Flynn Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
69
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
52.4%
Neutral
42.9%
Negative
4.8%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Equal-Weight
Downgraded
| $20 |
8%
downside
| 1 | +69% |
0
%
| 8 Jan ‘26 11 days ago |
|
|
|
Overweight
Upgraded
| $36 |
87%
upside
| 1 | +3.9% |
0
%
| 8 Jan ‘26 11 days ago |
|
|
|
Overweight
Maintained
| $33 |
38%
upside
| 1 | +158% |
0
%
| 7 Jan ‘26 11 days ago |
|
|
|
Overweight
Maintained
| $21 |
60%
upside
| 2 | -10% |
0
%
| 6 Jan ‘26 12 days ago |
|
|
|
Equal-Weight
Maintained
| $27 |
5%
upside
| 2 | – |
–
| 17 Dec ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $197 |
10%
downside
| 1 | – |
–
| 12 Dec ‘25 1 month ago |
|
|
|
Underweight
Maintained
| $37 |
33%
downside
| 1 | -7.7% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $102 |
6%
downside
| 3 | -2.8% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $125 |
41%
upside
| 1 | +31% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $304 |
8%
downside
| 2 | – |
–
| 12 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $269 |
25%
upside
| 1 | +3.4% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $564 |
28%
upside
| 2 | +1% |
0
%
| 5 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $1,290 |
24%
upside
| 2 | +7.8% |
0
%
| 24 Nov ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $9 |
3%
upside
| 1 | – |
–
| 11 Nov ‘25 2 months ago |
|